Trial Profile
Effect on Central and Peripheral Fatigue and Associated Biomarkers After Sustained Virologic Response (SVR) with Ledipasvir (LDV)/Sofosbuvir (SOF) in Patients with Chronic Hepatitis C Virus (CH-C)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 21 Aug 2015 New trial record